Methods of treatment with an ocular implant containing a tyrosine kinase inhibitor
US11534396B2 · kind B2 · utility
4Cited by
58References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 13, 2022 |
| Grant date | Dec 27, 2022 |
| Priority date | — |
| Expiry date | May 13, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to methods of treatment with a sustained release biodegradable ocular implant containing a tyrosine inhibitor dispersed in a hydrogel.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.